Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Inside Novo Nordisk’s Boldest Move Yet: A Weight-Loss Pill for the Masses Daniel Gilbert, Business of Medicine Reporter at The Washington Post, breaks down Nov...
Key Points Novo Nordisk has released a pill version of its GLP-1 drug. In 2025, the company announced that it was ending a GLP-1 trial related to the drug's i...
Barclays lowered the firm’s price target on Novo Nordisk (NVO) to DKK 360 from DKK 375 and keeps an Equal Weight rating on the shares. Claim 70% Off TipRanks P...
Analyst ratings
55%
of 33 ratingsMore NVO News
If you are wondering whether Novo Nordisk is attractively priced right now, the key question is whether the current share price reflects its long term prospects...
In brief Novo Nordisk rolled out an oral version of Wegovy in the U.S., marking the first pill-based GLP-1 approved specifically for weight loss. GLP-1 drugs f...
Novo Nordisk’s (NVO) head of public affairs in the U.S. Jennifer Duck has departed the company, Reuters’ Maggie Fick and Dan Levine report, citing an internal m...
Biotech and Pharma Novo Nordisk’s Wegovy Pill Hits Pharmacies. It’s the Latest Move in the Weight-Loss Showdown. In this article NOVO.B LLY GDRX The Wegovy pill...
Novo Nordisk’s wildly successful obesity medicine is now available as a pill, making it the first GLP-1 pill for weight loss in the United States. The pill is...
The stock of Eli Lilly (LLY) is down 4% on news that rival Novo Nordisk (NVO) has begun selling its highly anticipated weight-loss pill in the U.S. Claim 70% O...
Citi believes Novo Nordisk’s (NVO) announcement this morning that its Wegovy weight loss pill is now broadly available throughout the U.S. will pressure Hims &...